Clinical Trials
7 trialsNCT04523857 2026-05-26
ABBY
Abramson Cancer Center at Penn Medicine
Phase 2 Recruiting
NCT05576896 2026-05-26
Hydroxychloroquine in Combination With Encorafenib and Cetuximab or Panitumumab in the Treatment of Metastatic BRAF-mutated Colorectal Cancer Refractory
Northwestern University
Phase 2 Recruiting
NCT05365893 2026-05-22
PHL Treatment in Pancreatic Cancer
Fox Chase Cancer Center
Phase EARLY_PHASE1 Active not recruiting
NCT03598595 2026-05-14
Gemcitabine, Docetaxel, and Hydroxychloroquine in Treating Participants With Recurrent or Refractory Osteosarcoma
M.D. Anderson Cancer Center
Phase 1/2 Active not recruiting
NCT03825289 2026-05-14
THREAD
University of Utah
Phase 1 Terminated
NCT05036226 2026-05-13
COAST
Medical University of South Carolina
Phase 1/2 Recruiting
NCT04464759 2026-05-11
LIMIT
Abramson Cancer Center at Penn Medicine
Phase 1/2 Recruiting